Melasma treatment: a systematic review

References

• Zhou LL, Baibergenova A. Melasma: systematic review of the systemic treatments. Int J Dermatol. 2017;56(9):902–908.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zheng X, Chen Z, et al. Laser and laser compound therapy for melasma: a meta-analysis. J Dermatolog Treat. 2020;31(1):77–83.
   PubMed Web of Science ®Google Scholar
• Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive review. Dermatol Ther. 2017;7(3):305–318.
   PubMed Web of Science ®Google Scholar
• C GM, S K, Agrawal S, Melasma R. Through the eye of a dermoscope. Int J Res Dermatol. 2016;2(4):113.
   Google Scholar
• Kwon S-H, Hwang Y-J, Lee S-K, et al. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17(6):824–833.
   PubMed Web of Science ®Google Scholar
• Sarkar R, Bansal A, Ailawadi P. Future therapies in melasma: what lies ahead? Indian J Dermatol Venereol Leprol. 2020;86(1):8–17.
   PubMed Web of Science ®Google Scholar
• Kwon S-H, Na J-I, Choi J-Y, et al. Melasma: updates and perspectives. Exp Dermatol. 2019;28(6):704–708.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Arámbula A, Torres-Álvarez B, Cortés-García D, et al. CD4, IL-17, and COX-2 are associated with subclinical inflammation in malar melasma. Am J Dermatopathol. 2015;37(10):761–766.
   PubMed Web of Science ®Google Scholar
• Campuzano-García AE, Torres-Alvarez B, Hernández-Blanco D, et al. DNA methyltransferases in malar melasma and their modification by sunscreen in combination with 4% niacinamide, 0.05% retinoic acid, or placebo. BioMed Res Int. 2019;2019:1–7.
   Web of Science ®Google Scholar
• Yi J, Hong T, Zeng H, et al. A meta-analysis-based assessment of intense pulsed light for treatment of melasma. Aesth Plast Surg. 2020;44(3):947–952.
   PubMed Web of Science ®Google Scholar
• Ikino JK, Nunes DH, Silva V. P M d, et al. Melasma and assessment of the quality of life in Brazilian women*. An Bras Dermatol. 2015;90(2):196–200.
   PubMed Web of Science ®Google Scholar
• Rodrigues M, Pandya AG. Melasma: clinical diagnosis and management options. Australas J Dermatol. 2015;56(3):151–163.
   PubMed Web of Science ®Google Scholar
• Agamia N, Apalla Z, Salem W, et al. A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation. J Dermatol Treat.  2021;32(7):819–826.
   PubMed Web of Science ®Google Scholar
• Ahmed AM, Lopez I, Perese F, et al. A randomized, double-blinded, placebo-controlled trial of oral polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma. JAMA Dermatol. 2013;149(8):981–983.
   PubMed Web of Science ®Google Scholar
• Goh CL, Chuah SY, Tien S, et al. Double-blind, placebo-controlled trial to evaluate the effectiveness of polypodium leucotomos extract in the treatment of melasma in Asian Skin. J Clin Aesthet Dermatol. 2018;11(3):14–19.
   Google Scholar
• Colferai MMT, Miquelin GM, Steiner D. Evaluation of oral tranexamic acid in the treatment of melasma. J Cosmet Dermatol. 2019;18(5):1495–1501.
   PubMed Web of Science ®Google Scholar
• Del Rosario E, Florez-Pollack S, Zapata L, et al. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. J Am Acad Dermatol. 2018;78(2):363–369.
   PubMed Web of Science ®Google Scholar
• Emily Gan WLT. Double blind placebo controlled trial to evaluate of the effectiveness of a dietary supplement rich in carotenoids as adjunct to topical lightening cream for the treatment of melasma: a pilot study. J Pigment Disord. 2015;02(02):164–169.
   Google Scholar
• Hamadi S, Aljaf A, Abdulrazak A, et al. The role of topical and oral melatonin in management of melasma patients. J Arab Univ Basic Appl Sci. 2009;8:30–42.
   Google Scholar
• Handog EB, Galang DAVF, de Leon-Godinez MA, et al. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women. Int J Dermatol. 2009;48(8):896–901.
   PubMed Web of Science ®Google Scholar
• Karn D, Kc S, Amatya A, et al. Oral tranexamic acid for the treatment of melasma. Kathmandu Univ Med J. 2014;10(4):40–43.
   Google Scholar
• Khurana VK, Misri RR, Agarwal S, et al. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma. Indian J Dermatol Venereol Leprol. 2019;85(1):39–43.]
   PubMed Web of Science ®Google Scholar
• Lajevardi V, Ghayoumi A, Abedini R, et al. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up. J Cosmet Dermatol. 2017;16(2):235–242.
   PubMed Web of Science ®Google Scholar
• Martin l. A randomized double-blind placebo controlled study evaluating the effectiveness and tolerability of oral polypodium leucotomos in patients with melasma. J Am Acad Dermatol. 2012;66(4):AB21.
   Web of Science ®Google Scholar
• Minni K, Poojary S. Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single-centre, triple-blind, randomized, placebo-control, parallel group study. J Eur Acad Dermatol Venereol. 2020;34(11):2636–2644.
   PubMed Web of Science ®Google Scholar
• Padhi T/P. Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: an open labeled randomized comparative trial. PubMed Cent. 2015;60(5):520. DOI: 10.4103/0019-5154.164416
   Google Scholar
• Shin JU, Park J, Oh SH, et al. Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized. Dermatol Surg. 2013;39(3 Pt 1):435–442.
   PubMed Web of Science ®Google Scholar
• Sharma R, Mahajan VK, Mehta KS, et al. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clin Exp Dermatol. 2017;42(7):728–734.
   PubMed Web of Science ®Google Scholar
• Shihab N, Prihartono J, Tovar-Garza A, et al. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma. Australas J Dermatol. 2020;61(3):237–242.
   PubMed Web of Science ®Google Scholar
• Zhu C-Y, Li Y, Sun Q-N, et al. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study. Eur J Dermatol. 2019;29(1):55–58.
   PubMed Web of Science ®Google Scholar
• Balevi A, Ustuner P, Özdemir M. Salicylic acid peeling combined with vitamin C mesotherapy versus salicylic acid peeling alone in the treatment of mixed type melasma: a comparative study. J Cosmet Laser Ther. 2017;19(5):294–299.
   PubMed Web of Science ®Google Scholar
• Cassiano DP, Espósito ACC, Hassun KM, et al. Early clinical and histological changes induced by microneedling in facial melasma: a pilot study. Indian J Dermatol Venereol Leprol. 2019;85(6):638–641.
   PubMed Web of Science ®Google Scholar
• Elfar NN. Efficacy of intradermal injection of tranexamic acid, topical silymarin and glycolic acid peeling in treatment of melasma: a comparative study. J Clin Exp Dermatol Res. 2015;06(03):280–286.
   Google Scholar
• Hofny ERM, Abdel-Motaleb AA, Ghazally A, Ahmed AM, et al. Platelet-rich plasma is a useful therapeutic option in melasma. J Dermatol Treat. 2019;30(4):396–401.
   PubMed Web of Science ®Google Scholar
• Iraji F, Nasimi M, Asilian A, et al. Efficacy of mesotherapy with tranexamic acid and ascorbic acid with and without glutathione in treatment of melasma: a split face comparative trial. J Cosmet Dermatol. 2019;18(5):1416–1421.
   PubMed Web of Science ®Google Scholar
• Kaleem S, Ghafoor R, Khan S. Comparison of efficacy of tranexamic acid mesotherapy versus 0.9% normal saline for melasma; a split face study in a Tertiary Care Hospital of Karachi. Pak J Med Sci. 2020;36(5):930–934.
   PubMed Web of Science ®Google Scholar
• Pazyar N, Yaghoobi R, Zeynalie M, et al. Comparison of the efficacy of intradermal injected tranexamic acid vs hydroquinone cream in the treatment of melasma. CCID. 2019;12:115–122.
   Google Scholar
• Saki N, Darayesh M, Heiran A. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial. J Dermatol Treat. 2018;29(4):405–410.
   PubMed Web of Science ®Google Scholar
• Tehranchinia Z, Saghi B, Rahimi H. Evaluation of therapeutic efficacy and safety of tranexamic acid local infiltration in combination with topical 4% hydroquinone cream compared to topical 4% hydroquinone cream alone in patients with melasma: a split-face study. Dermatol Res Pract. 2018;2018:1–5.
   Web of Science ®Google Scholar
• Ustuner P, Balevi A, Ozdemir M. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma. J Cosmet Laser Ther. 2017;19(7):383–390.
   PubMed Web of Science ®Google Scholar
• Xu Y, Ma R, Juliandri J, et al. Efficacy of functional microarray of microneedles combined with topical tranexamic acid for melasma: a randomized, self-controlled, split-face study. Medicine. 2017;96(19):e6897.
   PubMed Web of Science ®Google Scholar
• Feng C, Yan M. Clinical observation on tranexamic acid combined with reduced glutathione for the treatment of chloasma. Pak J Pharm Sci. 2018;31(6):2823–2826.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li M, Zhang X, et al. Comparing the efficacy of Myjet-assisted tranexamic acid and vitamin C in treating melasma: a split-face controlled trial. J Cosmet Dermatol. 2020;19(1):47–54.
   PubMed Web of Science ®Google Scholar
• Abdel-Meguid AM, Taha EA, Ismail SA. Combined Jessner solution and trichloroacetic acid versus trichloroacetic acid alone in the treatment of melasma in dark-skinned patients. Dermatol Surg. 2017;43(5):651–656.
   PubMed Web of Science ®Google Scholar
• Dayal S, Sahu P, Dua R. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life. J Cosmet Dermatol. 2017;16(1):35–42.
   PubMed Web of Science ®Google Scholar
• Faghihi G/T. Solution of azelaic acid (20%), resorcinol (10%) and phytic acid (6%) versus glycolic acid (50%) peeling agent in the treatment of female patients with facial melasma. PubMed Cent. 2017;6:9–14.
   Google Scholar
• Garg S, Thami GP, Bhalla M, et al. Comparative efficacy of a 35% glycolic acid peel alone or in combination with a 10% and 20% trichloroacetic acid spot peel for melasma: a randomized control trial. Dermatol Surg. 2019;45(11):1394–1400.
   PubMed Web of Science ®Google Scholar
• Kanwar AJit, Parsad D, Kumaran M, et al. Glycolic acid peels/azelaic acid 20% cream combination and low potency triple combination lead to similar reduction in melasma severity in ethnic skin: results of a randomized controlled study. Indian J Dermatol. 2015;60(2):147–152.
   PubMed Web of Science ®Google Scholar
• Murtaza F, Bangash AR, Khushdil A, et al. Efficacy of trichloro-acetic acid peel alone versus combined topical magnesium ascorbyl phosphate for epidermal melasma. J Coll Physicians Surg–Pak JCPSP. 2016;26(7):557–561.
   PubMed Web of Science ®Google Scholar
• Sahu P/Y. Clinical efficacy and safety on combining 20% trichloroacetic acid peel with topical 5% ascorbic acid for melasma. PubMed Cent. 2017;11(9):WC08–WC11.
   Google Scholar
• Vachiramon V, Sahawatwong S, Sirithanabadeekul P. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling. Dermatol Surg. 2015;41(4):457–465.
   PubMed Web of Science ®Google Scholar
• Adalatkhah H, Sadeghi-Bazargani H. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial. Drug Des Devel Ther. 2015;9:4219–4225.
   PubMed Web of Science ®Google Scholar
• Arrowitz C, Schoelermann AM, Mann T, et al. Effective tyrosinase inhibition by thiamidol results in significant improvement of mild to moderate melasma. J Invest Dermatol. 2019;139(8):1691–1698.e6.
   PubMed Web of Science ®Google Scholar
• Atefi N, Dalvand B, Ghassemi M, et al. Therapeutic effects of topical tranexamic acid in comparison with hydroquinone in treatment of women with melasma. Dermatol Ther. 2017;7(3):417–424.
   PubMed Web of Science ®Google Scholar
• Banihashemi M, Zabolinejad N, Jaafari MR, et al. Comparison of therapeutic effects of liposomal tranexamic acid and conventional hydroquinone on melasma. J Cosmet Dermatol. 2015;14(3):174–177.
   PubMed Web of Science ®Google Scholar
• Boukari F, Jourdan E, Fontas E, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015;72(1):189–190.e1.
   PubMed Web of Science ®Google Scholar
• Bronzina E, Clement A, Marie B, et al. tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone. J Eur Acad Dermatol Venereol. 2020;34(4):897–903.
   PubMed Web of Science ®Google Scholar
• Draelos ZD. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone. J Am Acad Dermatol. 2015;72(1):105–107.
   PubMed Web of Science ®Google Scholar
• Eshghi G, Khezrian L, Esna Ashari F. Comparison between intralesional triamcinolone and Kligman’s formula in treatment of melasma. Acta Med Iran. 2016;54(1):67–71.
   PubMedGoogle Scholar
• Farshi S, Mansouri P, Kasraee B. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study. J Dermatolog Treat. 2018;29(2):182–189.
   PubMed Web of Science ®Google Scholar
• Fioranelli M, Jafferany M, Wollina U, et al. New local treatments for different types of melasma: vascular type vs nonvascular type. A randomized polycentric study. Dermatol Ther. 2020;33(3):e13300.
   PubMed Web of Science ®Google Scholar
• Gheisari M, Dadkhahfar S, Olamaei E, et al. The efficacy and safety of topical 5% methimazole vs. 4% hydroquinone in the treatment of melasma: a randomized controlled trial. J Cosmet Dermatol. 2020;19(1):167–172.
   PubMed Web of Science ®Google Scholar
• Gong Z, Lai W, Zhao G, et al. Efficacy and safety of fluocinolone acetonide, hydroquinone, and Tretinoin cream in Chinese patients with melasma: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study. Clin Drug Investig. 2015;35(6):385–395.
   PubMed Web of Science ®Google Scholar
• Ibrahim ZA, Gheida SF, El Maghraby GM, et al. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma. J Cosmet Dermatol. 2015;14(2):113–123.
   PubMed Web of Science ®Google Scholar
• Khosravan S, Alami A, Mohammadzadeh-Moghadam H, et al. The effect of topical use of Petroselinum crispum (parsley) versus that of hydroquinone cream on reduction of epidermal melasma: a randomized clinical trial. Holist Nurs Pract. 2017;b31(1):16–20.
   PubMed Web of Science ®Google Scholar
• Mansouri P, Farshi S, Hashemi Z, et al. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial. Br J Dermatol. 2015;173(1):209–217.
   PubMed Web of Science ®Google Scholar
• Mazurek K, Pierzchała E. Comparison of efficacy of products containing azelaic acid in melasma treatment. J Cosmet Dermatol. 2016;15(3):269–282.
   PubMed Web of Science ®Google Scholar
• Nofal A, Ibrahim A-SM, Nofal E, et al. Topical silymarin versus hydroquinone in the treatment of melasma: a comparative study. J Cosmet Dermatol. 2019;18(1):263–270.
   PubMed Web of Science ®Google Scholar
• Pratchyapurit W-O. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin. J Cosmet Dermatol. 2016;15(2):131–144.
   PubMed Web of Science ®Google Scholar
• Shamsi Meymandi S, Mohammadzadeh Shanehsaz S, Ansari Dogaheh M, et al. Efficacy of licorice extract in the treatment of melasma: a randomized, double-blind, placebo-controlled clinical trial. J Dermatol Cosmet. 2016;7(1):1–9.
   Google Scholar
• Taghavi F, Banihashemi M, Zabolinejad N, et al. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma. J Cosmet Dermatol. 2019;18(3):870–873.
   PubMed Web of Science ®Google Scholar
• Vachiramon V, Iamsumang W, Chanasumon N, et al. A study of efficacy and safety of high-intensity focused ultrasound for the treatment of melasma in Asians: a single-blinded, randomized, split-face, pilot study. J Cosmet Dermatol. 2020;19(2):375–381.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Tu Y, Gu H, et al. A cream of herbal mixture to improve melasma. J Cosmet Dermatol. 2019;18(6):1721–1728.
   PubMed Web of Science ®Google Scholar
• Janney MS, Subramaniyan R, Dabas R, et al. A randomized controlled study comparing the efficacy of topical 5% tranexamic acid solution versus 3% hydroquinone cream in melasma. J Cutan Aesthet Surg. 2019;12(1):63–67.
   PubMedGoogle Scholar
• Bae MI, Park JM, Jeong KH, et al. Effectiveness of low-fluence and short-pulse intense pulsed light in the treatment of melasma: a randomized study. J Cosmet Laser Ther. 2015;17(6):292–295.
   PubMed Web of Science ®Google Scholar
• Daniel B. Dual effect of photobiomodulation on melasma. J Clin Aesthet Dermatol. 2018;11(4):28–34.
   Google Scholar
• Chung JY, Lee JH, Lee JH. Topical tranexamic acid as an adjuvant treatment in melasma: Side-by-side comparison clinical study. J Dermatolog Treat. 2016;27(4):373–377.
   PubMed Web of Science ®Google Scholar
• Hassan AM, Elfar NN, Rizk OM, et al. Pulsed dye laser versus intense pulsed light in melasma: a split-face comparative study. J Dermatolog Treat. 2018;29(7):725–732.
   PubMed Web of Science ®Google Scholar
• Shakeeb N, Noor SM, Ullah G, et al. Efficacy of intense pulse light therapy and tripple combination cream versus intense pulse light therapy and tripple combination cream alone in epidermal melasma treatment. J Coll Physicians Surg Pak. 2018;28(1):13–16.
   PubMed Web of Science ®Google Scholar
• Yun WJ, Lee SM, Han JS, et al. A prospective, split-face, randomized study of the efficacy and safety of a novel fractionated intense pulsed light treatment for melasma in Asians. J Cosmet Laser Ther off Publ Eur Soc Laser Dermatol. 2015;17(5):259–266.
   PubMed Web of Science ®Google Scholar
• Abdel-Raouf Mohamed H, Ali Nasif G, Saad Abdel-Azim E, et al. Comparative study of fractional erbium: YAG laser vs. combined therapy with topical steroid as an adjuvant treatment in melasma. J Cosmet Dermatol. 2019;18(2):517–523.
   PubMed Web of Science ®Google Scholar
• Alavi S, Abolhasani E, Asadi S, et al. Combination of Q-switched Nd:YAG and fractional erbium:YAG lasers in treatment of melasma: a randomized controlled clinical trial. J Lasers Med Sci. 2017;(Winter)8(1);1–6.
   PubMed Web of Science ®Google Scholar
• Badawi A, Osman M. Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. CCID. 2018;11:13–20.
   Google Scholar
• Chalermchai T, Rummaneethorn P. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma. J Cosmet Laser Ther. 2018;20(3):134–139.
   PubMed Web of Science ®Google Scholar
• Choi Y-J, Nam J-H, Kim JY, et al. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: a prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial. Lasers Surg Med. 2017;49(10):899–907.
   PubMed Web of Science ®Google Scholar
• Choi CP, Yim SM, Seo SH, et al. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy. J Cosmet Laser Ther. 2015;17(1):2–8.
   PubMed Web of Science ®Google Scholar
• Guo X, Cai X, Jin Y, et al. Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: a prospective split-face study. Oncol Lett. 2019;18(4):4136–4143.
   PubMed Web of Science ®Google Scholar
• Hammami Ghorbel H, Boukari F, Fontas E, et al. Copper bromide laser vs triple-combination cream for the treatment of melasma: a randomized clinical trial. JAMA Dermatol. 2015;151(7):791–792.
   PubMed Web of Science ®Google Scholar
• Kong SH, Suh HS, Choi YS. Treatment of melasma with pulsed-dye laser and 1,064-nm Q-switched Nd:YAG laser: a split-face study. Ann Dermatol. 2018;30(1):1–7.
   PubMed Web of Science ®Google Scholar
• Laothaworn V, Juntongjin P. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma. J Cosmet Laser Ther off Publ Eur Soc Laser Dermatol. 2018;20(6):320–325.
   PubMed Web of Science ®Google Scholar
• Lee M-C, Chang C-S, Huang Y-L, et al. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study. Lasers Med Sci. 2015;30(1):159–163.
   PubMed Web of Science ®Google Scholar
• Lee M-C, Lin Y-F, Hu S, et al. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians. Lasers Med Sci. 2018;33(8):1733–1738.
   PubMed Web of Science ®Google Scholar
• Nourmohammadi Abadchi S, Fatemi Naeini F, Beheshtian E. Combination of hydroquinone and fractional CO2 laser versus hydroquinone monotherapy in melasma treatment: a randomized, single-blinded, split-face clinical trial. Indian J Dermatol. 2019;64(2):129–135.
   PubMed Web of Science ®Google Scholar
• Tawfic SO, Abdel Halim DM, Albarbary A, et al. Assessment of combined fractional CO2 and tranexamic acid in melasma treatment. Lasers Surg Med. 2019;51(1):27–33.
   PubMed Web of Science ®Google Scholar
• Vanaman Wilson MJ, Jones IT, Bolton J, et al. The safety and efficacy of treatment with a 1,927-nm diode laser with and without topical hydroquinone for facial hyperpigmentation and melasma in darker skin types. Dermatol Surg. 2018;44(10):1304–1310.
   PubMed Web of Science ®Google Scholar
• Wang Y-J, Lin E-T, Chen Y-T, et al. Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond Alexandrite laser with a diffractive lens array and triple combination cream in female Asian patients with melasma. J Eur Acad Dermatol Venereol. 2020;34(3):624–632.
   PubMed Web of Science ®Google Scholar
• Wanitphakdeedecha R, Sy-Alvarado F, Patthamalai P, et al. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study. Lasers Med Sci. 2020;35(9):2015–2021.
   PubMed Web of Science ®Google Scholar
• Sarma N, Chakraborty S, Poojary SA, et al. Evidence-based review, grade of recommendation, and suggested treatment recommendations for melasma. Indian Dermatol Online J. 2017;8(6):406–442.
   PubMedGoogle Scholar
• Garg S, Vashisht KR, Makadia S. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature. J Cosmet Laser Ther off Publ Eur Soc Laser Dermatol. 2019;21(5):297–307.
   PubMed Web of Science ®Google Scholar
• Wu SZ, Muddasani S, Alam M. A systematic review of the efficacy and safety of microneedling in the treatment of melasma. Dermatol Surg. 2020;46(12):1636–1641.
   PubMed Web of Science ®Google Scholar
• Conforti C, Zalaudek I, Vezzoni R, et al. Chemical peeling for acne and melasma: current knowledge and innovations. G Ital Dermatol E Venereol Organo Uff Soc Ital Dermatol E Sifilogr. 2020;155(3):280–285.
   PubMed Web of Science ®Google Scholar
• Dorgham NA, Hegazy RA, Sharobim AK, et al. Efficacy and tolerability of chemical peeling as a single agent for melasma in dark-skinned patients: a systematic review and meta-analysis of comparative trials. J Cosmet Dermatol. 2020;19(11):2812–2819.
   PubMed Web of Science ®Google Scholar
• Spierings NMK. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years. J Cosmet Dermatol. 2020;19(6):1284–1289.
   PubMed Web of Science ®Google Scholar
• Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. Int J Womens Dermatol. 2017;3(1):11–20.
   PubMedGoogle Scholar
• Aurangabadkar SJ. Optimizing Q-switched lasers for melasma and acquired dermal melanoses. Indian J Dermatol Venereol Leprol. 2019;85(1):10–17.
   PubMed Web of Science ®Google Scholar
• Shah SD, Aurangabadkar SJ. Laser toning in melasma. J Cutan Aesthet Surg. 2019;12(2):76–84.
   PubMedGoogle Scholar
• Masub N, Nguyen JK, Austin E, et al. The vascular component of melasma: a systematic review of laboratory, diagnostic, and therapeutic evidence. Dermatol Surg. 2020;46(12):1642–1650.
   PubMed Web of Science ®Google Scholar